BLUE long if strong tomorrow

Bluebird has been a strong performer over the past year, which is now testing support. It probed its rising trendline support yesterday, and today dropped below that and tested its 100-day SMA . It seems that valuation concerns are the reason that the selling got underway a couple of days ago. But I haven't read anything negative about the strength of their pipeline. I do agree that a $10B market cap is a lot for a pre-revenue biotech. But there are some very large indications getting addressed by BLUE (sickle-cell disease and myeloma, just to name two). I am not sure what to make of the CELG partnership, now that CELG has bought BLUE competitor JUNO. But all in all, I do like BLUE for a bounce after 7 days of selling. If it's green tomorrow, I would favor a long entry.
Mar 23
Comment: I wound up getting into BLUE a day too soon. Still did fine today, despite some brutal market conditions. I wound up selling half of my position into the close today, because I wanted to lighten up on highly volatile names in this already volatile market. Looks good for Monday, though.
Home Stock Screener Forex Screener Crypto Screener Economic Calendar Shows How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Help Center Refer a friend Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out